agilon health (AGL) stock: insider trades, news & valuation
Net buyingShare price and insider trades
agilon health insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $351K and 0 sold $0 of AGL stock on the open market.
Get emailed when insiders cluster-buy stocks like AGL
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
AGL insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $300K | 1 | — | 0 |
| Q4 2025 | $51K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 agilon health, inc. insiders reported open-market purchases totaling $351K, while 0 insiders reported sales totaling $0.
AGL earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 5, 2026 | -22.4% | None | -8.4%S&P -0.4% | +1.9% |
| May 6, 2026 | -5.5% | None | +126.9%S&P +1.1% | +59.7% |
| Feb 25, 2026 | -35.9% | None | +51.0%S&P +0.3% | -33.4% |
| Nov 4, 2025 | -15.6% | None | -6.9%S&P -0.8% | -13.5% |
| Aug 4, 2025 | -21.7% | None | -48.2%S&P +1.0% | +37.5% |
| May 6, 2025 | +3.0% | None | -17.7%S&P -0.4% | -36.3% |
| Feb 25, 2025 | +9.3% | None | -7.7%S&P -0.4% | +33.6% |
| Nov 7, 2024 | +2.1% | None | -36.1%S&P +1.2% | +17.9% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 11SEC | Girish VenkatachaliahCTO | Buy | 18,448285,084 held (+7%) | — | $0 | — | — |
| Mar 11SEC | Denise ZamoreGeneral Counsel | Buy | 5,535448,660 held (+1%) | — | $0 | — | — |
| Mar 11SEC | Benjamin ShakerChief Markets Officer | Buy | 18,4481,386,122 held (+1%) | — | $0 | — | — |
| Mar 3SEC | Benjamin ShakerChief Markets Officer | Buy | 500,0001,367,674 held (+58%) | $0.60 | $300K | +13631.7% | — |
| Jan 30SEC | John William WulfDirector | Buy | 81,000365,857 held (+28%) | $0.63 | $51K | +12977.8% | — |
Insiders at agilon health, inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Benjamin ShakerChief Markets Officer | $300K | — | Mar 11, 2026 | — |
| John William WulfDirector | $51K | — | Jan 30, 2026 | — |
| Girish VenkatachaliahCTO | — | — | Mar 11, 2026 | — |
| Denise ZamoreGeneral Counsel | — | — | Mar 11, 2026 | — |
AGL stock: common questions
Are agilon health, inc. insiders buying AGL stock?
In the past 12 months, 2 insiders reported open-market purchases of AGL worth $351K. The latest was CTO Girish Venkatachaliah bought $0 of AGL.
Are agilon health, inc. insiders selling AGL stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is AGL's 52-week range?
Over the past year AGL has traded between $7.91 and $129.84. It last closed at $82.39 on Oct 9, 2026.